Brief: Phio Pharmaceuticals Names Robert Bitterman As Chief Executive Officer

Phio Pharmaceuticals

22/02/2023 12:43

Feb 22 (Reuters) - Phio Pharmaceuticals Corp  PHIO.O :
    * PHIO PHARMACEUTICALS APPOINTS ROBERT BITTERMAN AS
PRESIDENT AND
CHIEF EXECUTIVE OFFICER
    * PHIO PHARMACEUTICALS CORP - ROBERT BITTERMAN HAS BEEN
APPOINTED
BY BOARD TO SERVE AS CO'S PRESIDENT AND CEO, EFFECTIVE AS OF
FEBRUARY 20, 2023
    * PHIO PHARMACEUTICALS CORP - BITTERMAN HAS SERVED AS
INTERIM
CHIEF EXECUTIVE OFFICER SINCE SEPTEMBER 2022
    * PHIO PHARMACEUTICALS CORP - BITTERMAN WILL CONTINUE TO
SERVE AS
CHAIR OF BOARD, & AS CO'S PRINCIPAL EXECUTIVE OFFICER AND
PRINCIPAL FINANCIAL OFFICER

Source text for Eikon:  ID:nPn35lXYsa 
Further company coverage:  PHIO.O 
 ((Reuters.Briefs@thomsonreuters.com;))